Zanosar

Zanosar is a brand name of streptozocin, approved by the FDA in the following formulation(s):

ZANOSAR (streptozocin - injectable; injection)

• 
  Manufacturer: TEVA PARENTERAL
  
  Approval date: May 7, 1982
  
  Strength(s): 1GM/VIAL ^[RLD]

Has a generic version of Zanosar been approved?

No. There is currently no therapeutically equivalent version of Zanosar available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zanosar. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Zanosar.

See also...

• Zanosar Consumer Information (Wolters Kluwer)
• Zanosar Consumer Information (Cerner Multum)
• Zanosar Advanced Consumer Information (Micromedex)
• Zanosar AHFS DI Monographs (ASHP)
• Streptozocin Consumer Information (Wolters Kluwer)
• Streptozocin Consumer Information (Cerner Multum)
• Streptozocin Intravenous Advanced Consumer Information (Micromedex)
• Streptozocin AHFS DI Monographs (ASHP)